Key Takeaways From C4 Therapeutics Analyst Ratings
C4 Therapeutics (NASDAQ:CCCC) underwent analysis by 4 analysts in the last quarter, revealing a spectrum of viewpoints from…
C4 Therapeutics Presents New Preclinical Data For CFT1946 Highlighting Superior Activity As A Single Agent To Clinically Approved BRAF Inhibitor Standard Of Care Combinations At The American Association For Cancer Research Annual Meeting 2024
C4 Therapeutics, Inc. (C4T) (NASDAQ:CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, presented a poster today at the American Association for Cancer Research
Capital One Financial To Acquire Discover, Joins SSR Mining And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session
U.S. stock futures were lower this morning, with the Dow futures trading lower by around 50 points on Tuesday.
Analyst Expectations For C4 Therapeutics’s Future
Throughout the last three months, 5 analysts have evaluated C4 Therapeutics (NASDAQ:CCCC), offering a diverse set of opinions…
C4 Therapeutics Announces 2024 Priorities; Unaudited Cash, Cash Equivalents and Marketable Securities Totaling ~$330M As of January 5, 2024 To Advance Portfolio Of Targeted Protein Degradation Medicines; Announces Workforce Reduction Of ~30%
Multiple 2024 Clinical Updates Expected, Including Data from the Ongoing CFT7455 and CFT1946 Phase 1 Dose Escalation Trials Prioritization of CFT7455, CFT1946, Discovery Collaborations and Focused Discovery Research
What’s Going On With C4 Therapeutics Stock?
C4 Therapeutics, Inc. (NASDAQ: CCCC) shares are trading higher Friday, and the stock has gained more than 350% over the past five days.
Benzinga’s ‘Stock Whisper’ Index: 5 Stocks Investors Secretly Monitor But Don’t Talk About Yet
A look at five stocks that saw increased interest from Benzinga readers during the week.
12 Health Care Stocks Moving In Friday’s Pre-Market Session
Gainers Heart Test Laboratories (NASDAQ:HSCS) stock rose 27.1% to $0.2 during Friday’s pre-market session. The company’s market cap…
Dow Jumps Over 200 Points; Federal Reserve Holds Interest Rates Steady
U.S. stocks traded higher toward the end of trading, after the Federal Reserve announced its policy decision on Wednesday.
The Dow traded up 0.58% to 36,789.77 while the NASDAQ rose 0.63% to 14,624.74. The S&P 500 also rose, gaining, 0.62% to 4,672.48.
Why Despegar.com Shares Are Trading Higher By Over 16%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session
Shares of Despegar.com, Corp. (NYSE: DESP) rose sharply during Wednesday’s session after the company raised its FY23 financial guidance.
The company said it now sees revenue of $690 million to $700 million, versus previous forecast of $670 million to $700 million.